Cosmo Robotics submits securities report, begins KOSDAQ listing process

Cosmo Robotics (CEOs Jooyoung Oh and Gon Kang), a global wearable robot company, announced on the 11th that it has submitted a securities report to the Financial Services Commission and has begun the full-scale process for listing on KOSDAQ.

A total of 4.17 million shares will be offered through this listing, with a target offering price of KRW 5,300 to KRW 6,000. The anticipated offering value is approximately KRW 22.1 billion to KRW 25 billion. The institutional investor demand forecast will run for five days, from March 9th to 13th, while the general investor subscription will run for two days, from March 18th to 19th. The lead underwriters for the listing are Eugene Investment & Securities and NH Investment & Securities.

Founded in 2016, Cosmo Robotics is a company specializing in wearable robotics for the medical and rehabilitation sectors. Its products include "Bambini Kids," a rehabilitation robot for infants and toddlers, "Bambini Teens," a youth-focused robot, "EA2 PRO," a rehabilitation robot for adults, "COSuit," a walking assistance robot, and "EA personal," a personalized walking assistance solution. The company is expanding its business in the domestic and international rehabilitation medical markets.

The company announced that it has obtained U.S. Food and Drug Administration (FDA) certification and European Conformity (CE) certification, and has received approvals in 12 countries worldwide. Building on this, the company is expanding its business competitiveness in the global market.

Cosmo Robotics plans to expand its business beyond its existing B2B business focused on medical institutions into the B2C market, encompassing home wearable robots, walking assistance robots, and muscle-assist robots. Furthermore, the company plans to expand its wearable robots beyond the medical and rehabilitation sectors and into everyday life through strategies such as overseas expansion and expansion into the government procurement market.

The company targets the global market through five overseas subsidiaries, including those in the US, China, and the European Union. Last year, it received the "$3 Million Export Tower Award." This achievement represents a tripling of exports in just one year, following its "$1 Million Export Tower Award" in 2024.

CEO Oh Joo-young said, “Through continuous research and development and investment, we have advanced rehabilitation robot technology that covers all age groups, from infants to adults,” and “With the KOSDAQ listing as an opportunity, we will focus on strengthening our technological competitiveness and expanding into the global market.”

Meanwhile, Cosmo Robotics passed the technology evaluation for KOSDAQ technology special listing by receiving A and BBB ratings from Korea Ratings Data and Nice D&B, professional rating agencies designated by the Korea Exchange, respectively, in June of last year.


  • See more related articles